{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T03:59:53Z","timestamp":1781495993158,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T00:00:00Z","timestamp":1537142400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s10096-018-3376-6","type":"journal-article","created":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T00:57:33Z","timestamp":1537145853000},"page":"2307-2312","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The effect of short-course gentamicin therapy on kidney function in patients with bacteraemia\u2014a retrospective cohort study"],"prefix":"10.1007","volume":"37","author":[{"given":"Sarah","family":"Carlsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3085-0930","authenticated-orcid":false,"given":"Jonas","family":"Boel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Otto","family":"Jarl\u00f8v","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Gj\u00f8rup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"S\u00f8borg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Arpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,17]]},"reference":[{"key":"3376_CR1","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1046\/j.1525-1497.1998.00224.x","volume":"13","author":"DL Paterson","year":"1998","unstructured":"Paterson DL, Robson JMB, Wagener MM (1998) Risk factors for toxicity in elderly patients given aminoglycosides once daily. J Gen Intern Med 13:735\u2013739. \n                    https:\/\/doi.org\/10.1046\/j.1525-1497.1998.00224.x","journal-title":"J Gen Intern Med"},{"key":"3376_CR2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1177\/0897190014546836","volume":"27","author":"KA Wargo","year":"2014","unstructured":"Wargo KA, Edwards JD (2014) Aminoglycoside-induced nephrotoxicity. J Pharm Pract 27:573\u2013577. \n                    https:\/\/doi.org\/10.1177\/0897190014546836","journal-title":"J Pharm Pract"},{"key":"3376_CR3","doi-asserted-by":"publisher","first-page":"CD003344","DOI":"10.1002\/14651858.CD003344.pub3","volume":"1","author":"M Paul","year":"2014","unstructured":"Paul M, Lador A, Grozinsky-Glasberg S, Leibovici L (2014) Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis. Cochrane Database Syst Rev 1:CD003344. \n                    https:\/\/doi.org\/10.1002\/14651858.CD003344.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"3376_CR4","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1128\/AAC.39.3.650","volume":"39","author":"DP Nicolau","year":"1995","unstructured":"Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH, Ross JW, Quintiliani R (1995) Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother 39:650\u2013655","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"3376_CR5","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1093\/cid\/cix186","volume":"64","author":"David S. Y. Ong","year":"2017","unstructured":"Ong DSY, Frencken JF, Klouwenberg K, C PM, Juffermans N, van der Poll T, et al. Short-course adjunctive gentamicin as empirical therapy in patients with severe sepsis and septic shock: a prospective observational cohort study. Clin Infect Dis 2017 64:1731\u20136. doi: \n                    https:\/\/doi.org\/10.1093\/cid\/cix186","journal-title":"Clinical Infectious Diseases"},{"key":"3376_CR6","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.jtcvs.2014.05.090","volume":"148","author":"DV Nielsen","year":"2014","unstructured":"Nielsen DV, Fedosova M, Hjortdal V, Jakobsen C-J (2014) Is single-dose prophylactic gentamicin associated with acute kidney injury in patients undergoing cardiac surgery? A matched-pair analysis. J Thorac Cardiovasc Surg 148:1634\u20131639. \n                    https:\/\/doi.org\/10.1016\/j.jtcvs.2014.05.090","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3376_CR7","doi-asserted-by":"publisher","first-page":"953","DOI":"10.3109\/00365548.2011.601755","volume":"43","author":"MH Spanggaard","year":"2011","unstructured":"Spanggaard MH, Honge BL, Schonheyder HC, Nielsen H (2011) Short-term gentamicin therapy and risk of renal toxicity in patients with bacteraemia. Scand J Infect Dis 43:953\u2013956. \n                    https:\/\/doi.org\/10.3109\/00365548.2011.601755","journal-title":"Scand J Infect Dis"},{"key":"3376_CR8","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3109\/23744235.2015.1109136","volume":"48","author":"M Cobussen","year":"2016","unstructured":"Cobussen M, de Kort JML, Dennert RM, Lowe SH, Stassen PM (2016) No increased risk of acute kidney injury after a single dose of gentamicin in patients with sepsis. Infect Dis 48:274\u2013280. \n                    https:\/\/doi.org\/10.3109\/23744235.2015.1109136","journal-title":"Infect Dis"},{"key":"3376_CR9","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/Jac\/Dkm354","volume":"60","author":"M Freundlich","year":"2007","unstructured":"Freundlich M, Thomsen RW, Pedersen L, West H, Schonheyder HC (2007) Aminoglycoside treatment and mortality after bacteraemia in patients given appropriate empirical therapy: a Danish hospital-based cohort study. J Antimicrob Chemother 60:1115\u20131123. \n                    https:\/\/doi.org\/10.1093\/Jac\/Dkm354","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"3376_CR10","doi-asserted-by":"publisher","first-page":"7468","DOI":"10.1128\/AAC.03750-14","volume":"58","author":"W Picard","year":"2014","unstructured":"Picard W, Bazin F, Clouzeau B, Bui H-N, Soulat M, Guilhon E et al (2014) Propensity-based study of aminoglycoside nephrotoxicity in patients with severe sepsis or septic shock. Antimicrob Agents Chemother 58(12):7468\u20137474. \n                    https:\/\/doi.org\/10.1128\/AAC.03750-14","journal-title":"Antimicrob Agents Chemother"},{"key":"3376_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1471-2288-12-139","volume":"12","author":"KO Gradel","year":"2012","unstructured":"Gradel KO, Knudsen JD, Arpi M, \u00d8stergaard C, Sch\u00f8nheyder HC, S\u00f8gaard M (2012) Classification of positive blood cultures: computer algorithms versus physicians\u2019 assessment - development of tools for surveillance of bloodstream infection prognosis using population-based laboratory databases. BMC Med Res Methodol 12:139. \n                    https:\/\/doi.org\/10.1186\/1471-2288-12-139","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"3376_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1197\/jamia.M3196","volume":"17","author":"B Hota","year":"2010","unstructured":"Hota B, Lin M, Doherty JA, Borlawsky T, Woeltje K, Stevenson K et al (2010) Formulation of a model for automating infection surveillance: algorithmic detection of central-line associated bloodstream infection. J Am Med Inform Assoc 17(1):42\u201348. \n                    https:\/\/doi.org\/10.1197\/jamia.M3196","journal-title":"J Am Med Inform Assoc"},{"key":"3376_CR13","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1093\/clinids\/11.6.1029","volume":"11","author":"FJ Roberts","year":"1989","unstructured":"Roberts FJ (1989) Definition of polymicrobial bacteremia. Rev Infect Dis 11:1029\u20131030. \n                    https:\/\/doi.org\/10.1093\/clinids\/11.6.1029","journal-title":"Rev Infect Dis"},{"issue":"1","key":"3376_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/ckj\/sfs160","volume":"6","author":"JA Lopes","year":"2013","unstructured":"Lopes JA, Jorge S (2013) The RIFLE and AKIN classifications for acute kidney injury: a critical and comprehensive review. Clin Kidney J 6(1):8\u201314. \n                    https:\/\/doi.org\/10.1093\/ckj\/sfs160","journal-title":"Clin Kidney J"},{"key":"3376_CR15","doi-asserted-by":"publisher","unstructured":"Section 2 (2012) AKI Definition. Kidney. Int. Suppl (1, 2):19\u201336. \n                    https:\/\/doi.org\/10.1038\/kisup.2011.32","DOI":"10.1038\/kisup.2011.32"},{"key":"3376_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrneph.2017.2","volume":"13","author":"LS Chawla","year":"2017","unstructured":"Chawla LS, Bellomo R, Bihorac A, Goldstein SL, Siew ED, Bagshaw SM et al (2017) Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol 13:241\u2013257. \n                    https:\/\/doi.org\/10.1038\/nrneph.2017.2","journal-title":"Nat Rev Nephrol"},{"key":"3376_CR17","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"J-L Vincent","year":"1996","unstructured":"Vincent J-L, Moreno R, Takala J, Willatts S, Mendon\u00e7a AD, Bruining H et al (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. Intensive Care Med 22:707\u2013710. \n                    https:\/\/doi.org\/10.1007\/BF01709751","journal-title":"Intensive Care Med"},{"issue":"1","key":"3376_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/ki.2010.337","volume":"79","author":"JM Lopez-Novoa","year":"2011","unstructured":"Lopez-Novoa JM, Quiros Y, Vicente L, Morales AI, Lopez-Hernandez FJ (2011) New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney Int 79(1):33\u201345. \n                    https:\/\/doi.org\/10.1038\/ki.2010.337","journal-title":"Kidney Int"},{"key":"3376_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1177\/106002800303700203","volume":"37","author":"AM Baciewicz","year":"2003","unstructured":"Baciewicz AM, Sokos DR, Cowan RI (2003) Aminoglycoside-associated nephrotoxicity in the elderly. Ann Pharmacother 37:182\u2013186. \n                    https:\/\/doi.org\/10.1177\/106002800303700203","journal-title":"Ann Pharmacother"},{"key":"3376_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0002-9343(96)80074-X","volume":"101","author":"J Koo","year":"1996","unstructured":"Koo J, Tight R, Rajkumar V, Hawa Z (1996) Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients. Am J Med 101:177\u2013183. \n                    https:\/\/doi.org\/10.1016\/S0002-9343(96)80074-X","journal-title":"Am J Med"},{"key":"3376_CR21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1592\/phco.21.5.443.34490","volume":"21","author":"DS Streetman","year":"2001","unstructured":"Streetman DS, Nafziger AN, Destache CJ, Bertino JS (2001) Individualized pharmacokinetic monitoring results in less aminoglycoside-associated nephrotoxicity and fewer associated costs. Pharmacother J Hum Pharmacol Drug Ther 21:443\u2013451. \n                    https:\/\/doi.org\/10.1592\/phco.21.5.443.34490","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"issue":"7","key":"3376_CR22","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1128\/AAC.01430-08","volume":"53","author":"JFP Oliveira","year":"2009","unstructured":"Oliveira JFP, Silva CA, Barbieri CD, Oliveira GM, Zanetta DMT, Burdmann EA (2009) Prevalence and risk factors for aminoglycoside nephrotoxicity in intensive care units. Antimicrob Agents Chemother 53(7):2887\u20132891. \n                    https:\/\/doi.org\/10.1128\/AAC.01430-08","journal-title":"Antimicrob Agents Chemother"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-018-3376-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3376-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3376-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T19:16:35Z","timestamp":1568661395000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-018-3376-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,17]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3376"],"URL":"https:\/\/doi.org\/10.1007\/s10096-018-3376-6","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,17]]},"assertion":[{"value":"13 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the National Health Board Journal (record number: 3-3013-804\/1\/) and the Danish Data Protection Agency (record number: HEH-2014-096-03258).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}